RAREPLEX
Live / Registered — Registered (as of 01 Feb 2022)
What this means for you
Registered since 01 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88088613
- Registration number
- 6634093
- Mark type
- Stylized text
- Filed
- 22 Aug 2018
- Published for opposition
- 06 Nov 2018
- Registered
- 01 Feb 2022
- Attorney of record
- Gabrielle A. Holley
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic reagents and assays for testing of biological samples
Owner
- RareCyte, Inc., Seattle, WA, US
- RareCyte, Inc., Seattle, WA, US
- RareCyte, Inc., Seattle, WA, US
Prior registrations
Prosecution history
- 01 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Dec 2021 — USE AMENDMENT FILED
- 15 Dec 2021 — TEAS STATEMENT OF USE RECEIVED
- 24 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2021 — SOU EXTENSION 5 GRANTED
- 03 Jun 2021 — SOU EXTENSION 5 FILED
- 22 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Dec 2020 — SOU EXTENSION 4 GRANTED
- 07 Dec 2020 — SOU EXTENSION 4 FILED
- 07 Dec 2020 — SOU TEAS EXTENSION RECEIVED